[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366801-105":3,"doc-detail-366801-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hmmr-in-human-cancers-regulatory-mechanism-and-biological-function-review","HMMR in human cancers - regulatory mechanism and biological function - review","","Hyaluronan-mediated motility receptor (HMMR), also known as RHAMM or CD168, is a multifunctional protein that converts extracellular matrix-derived hyaluronan signals into intracellular pathways controlling tumor growth, migration, and mitosis. HMMR is overexpressed across multiple cancers, and higher levels associate with poor prognosis, supporting its use in survival prediction and risk stratification. Functionally, HMMR promotes progression and metastasis via oncogenic pathway activation and roles in spindle assembly, cell polarity, and mitotic fidelity, while shaping an immunosuppressive tumor microenvironment and maintaining cancer stem cells. Emerging therapeutic strategies include peptide mimetics that block HA binding, HMMR-based vaccines, and HA synthesis inhibitors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hmmr-in-human-cancers-regulatory-mechanism-and-biological-function-review/366801/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hmmr-in-human-cancers-regulatory-mechanism-and-biological-function-review/366801.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is HMMR and what does it mediate in cancers?","Question",{"text":63,"@type":64},"HMMR is an hyaluronan-mediated motility receptor (also RHAMM/CD168) that transmits extracellular hyaluronan signals to intracellular pathways regulating tumor growth, migration, and mitosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does HMMR overexpression relate to prognosis?",{"text":68,"@type":64},"Overexpression of HMMR is observed in many cancers and correlates with poor prognosis, making it useful for survival prediction and risk stratification.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are small-molecule inhibitors challenging for HMMR, and what alternatives are being explored?",{"text":72,"@type":64},"Its coiled-coil structural characteristics complicate traditional small-molecule inhibition. Strategies under exploration include peptide mimetics blocking HA binding, HMMR-based tumor vaccines, and inhibitors of HA synthesis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366801,1790197168,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2",8,"Hu etal. Journal of Translational Medicine (2025) 23:1302  \n[https://doi.org/10.1186/s12967-025-07260-1](https://doi.org/10.1186/s12967-025-07260-1)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nHMMR in human cancers: regulatory mechanism and biological function  \nYanghao Hu 1,2†, Yifei Zhang 1,2†, Jiali He 1,2, Huihuang Rao 1,2, Zhengyu Wei3, Zhisen Shen 1* and Chongchang Zhou 1*  \nAbstract  \nHyaluronan-mediated motility receptor (HMMR), also referred to as RHAMM or CD168, has gained recognition asa multifunctional protein that mediates the transmission of extracellular matrix-derived hyaluronan (HA) signals to intracellular pathways regulating tumor growth, migration, and mitosis. Overexpression of HMMR is observed in various cancers, including head and neck squamous cell carcinoma, breast cancer, lung cancer, and prostate cancer, as well as several hematologic malignancies. This elevated expression correlates with poor prognosis, rendering it a valuable marker for survival prediction and risk stratification. Functionally, HMMR facilitates tumor progression and metastasis by activating multiple oncogenic pathways and coordinating spindle assembly, cell polarity, and mitotic fidelity. Additionally, HMMR plays a key role forming an immunosuppressive tumor microenvironment and supporting the maintenance of cancer stem cells, collectively driving metastasis, therapeutic resistance, and adverse clinical outcomes. These diverse functions position HMMR as both a promising prognostic biomarker anda potential therapeutic target. However, its coiled-coil structural characteristics present significant challenges for traditional small-molecule inhibition. In response, emerging strategies such as peptide mimetics that competitively inhibit HA binding, HMMR-based tumor vaccines, and HA synthesis inhibitors are being explored to counteract HMMR-driven oncogenic activities. This review offers a comprehensive overview of HMMR‘s discovery, structural domains, isoform diversity, upstream regulatory networks, and key signaling pathways, underscoring its biological relevance and clinical significance across various cancers while clarifying the tumor and context specific roles of HMMR and its structural and functional complexity.  \nKeywords HMMR, Biomarker, Cancer progression and metastasis, Immunosuppressive tumor microenvironment, Therapeutic targeting  \n†Yanghao Hu andYifei Zhang contributed equally to this work.  \n*Correspondence: Zhisen Shen [szs7216@163.com](szs7216@163.com)[ ](szs7216@163.com)Chongchang Zhou  \n[zhou900709900709@163.com](zhou900709900709@163.com)  \n1Department of Otorhinolaryngology Head and Neck Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China 2Ningbo University Health Science Center, Ningbo University, Ningbo, Zhejiang, China  \n3Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecom","cbCaib8B6M7cu2xM","https://ap.wps.com/l/cbCaib8B6M7cu2xM","pdf",3062998,28,"English","# Background\n## Hyaluronan (HA) and its biological roles\n## HA receptors and CD44 signaling\n## HMMR as an HA receptor\n# Review Focus\n## Discovery, structural domains, and isoform diversity\n## Upstream regulatory networks and key signaling pathways\n## Clinical relevance and therapeutic implications","[{\"question\":\"What is HMMR and what does it mediate in cancers?\",\"answer\":\"HMMR is an hyaluronan-mediated motility receptor (also RHAMM/CD168) that transmits extracellular hyaluronan signals to intracellular pathways regulating tumor growth, migration, and mitosis.\"},{\"question\":\"How does HMMR overexpression relate to prognosis?\",\"answer\":\"Overexpression of HMMR is observed in many cancers and correlates with poor prognosis, making it useful for survival prediction and risk stratification.\"},{\"question\":\"Why are small-molecule inhibitors challenging for HMMR, and what alternatives are being explored?\",\"answer\":\"Its coiled-coil structural characteristics complicate traditional small-molecule inhibition. Strategies under exploration include peptide mimetics blocking HA binding, HMMR-based tumor vaccines, and inhibitors of HA synthesis.\"}]","HMMR in human cancers - regulatory mechanism and biological function - review | PDF",1790167571,71,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f77ffc4fbaeb1691ff733db2c2fc367.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc19eccaeb4eca6f6a1b65c05caa2791.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c88f9847ab7f25671e0e2b0d0317f27a.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/509e961d1f6fd05d0575e32518b37ad3.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]